Botulinum Toxin Type A: Implications in Wound Healing, Facial Cutaneous Scarring, and Cleft Lip Repair

Overview

Journal Ann Saudi Med

Specialty General Medicine

Date 2013 Nov 6

PMID 24188943

Citations 12

Authors

Mohammad M Al-Qattan

Bisher Nawras Al-Shanawani

Feras Alshomer

Affiliations

Soon will be listed here.

Abstract

Botulinum toxin is a neurotoxin that has been utilized to induce chemo-denervation of muscles. Cutaneous wounds represent a special situation in which the tensile forces applied by these muscles on wound edges might have deleterious effects on the healing process. The aim of this review was to investigate such an effect and to review other mechanisms this toxin might have on the healing process. We also reviewed the role of botulinum toxin in the management of hypertrophic scars and cleft lip repair.

Citing Articles

Exploring New and Potential Indications for Botulinum Toxin Treatment: An Updated Literature Review.

Wen J, Nadora D, Ansari U, Syed B, Shehabat M, Razick D Cureus. 2025; 16(12):e75549.

PMID: 39803022 PMC: 11722663. DOI: 10.7759/cureus.75549.

Botox: Current and Emerging Trends for Dental Practitioners in Esthetic Dentistry.

Rambole O, Reche A, Paul P Cureus. 2024; 16(7):e64052.

PMID: 39114247 PMC: 11305439. DOI: 10.7759/cureus.64052.

Evaluation of the Effect of Botulinum Toxin A on the Lymphatic Endothelial Cells.

Vasella M, Wolf S, Grunherz L, Kim B, Lindenblatt N, Giovanoli P Aesthetic Plast Surg. 2024; 48(21):4513-4522.

PMID: 38839615 PMC: 11588844. DOI: 10.1007/s00266-024-04061-7.

Natural Compounds and Biomimetic Engineering to Influence Fibroblast Behavior in Wound Healing.

Berry C, Brenac C, Gonzalez C, Kendig C, Le T, An N Int J Mol Sci. 2024; 25(6).

PMID: 38542247 PMC: 10970265. DOI: 10.3390/ijms25063274.

Five decades of the use of botulinum toxin in ophthalmology.

Leszczynska A, Nowicka D, Pillunat L, Szepietowski J Indian J Ophthalmol. 2024; 72(6):789-795.

PMID: 38317306 PMC: 11232847. DOI: 10.4103/IJO.IJO_1030_23.

References

Wilson A . Use of botulinum toxin type A to prevent widening of facial scars. Plast Reconstr Surg. 2006; 117(6):1758-66. DOI: 10.1097/01.prs.0000209944.45949.d1. View

Carruthers J, Carruthers A . BOTOX use in the mid and lower face and neck. Semin Cutan Med Surg. 2001; 20(2):85-92. DOI: 10.1053/sder.2001.25139. View

Scott A, Rosenbaum A, Collins C . Pharmacologic weakening of extraocular muscles. Invest Ophthalmol. 1973; 12(12):924-7. View

Frankel A, Markarian A . Cosmetic treatments and strategies for the upper face. Facial Plast Surg Clin North Am. 2007; 15(1):31-9, vi. DOI: 10.1016/j.fsc.2006.11.004. View

Xiao Z, Zhang F, Cui Z . Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. Aesthetic Plast Surg. 2009; 33(3):409-12. DOI: 10.1007/s00266-009-9334-z. View

Lebeda F, Dembek Z, Adler M . Kinetic and reaction pathway analysis in the application of botulinum toxin a for wound healing. J Toxicol. 2011; 2012:159726. PMC: 3235895. DOI: 10.1155/2012/159726. View

Gonzalez-Ulloa M . Restoration of the face covering by means of selected skin in regional aesthetic units. Br J Plast Surg. 1956; 9(3):212-21. DOI: 10.1016/s0007-1226(56)80036-2. View

Goz G, Joos U, SCHILLI W . The influence of lip function on the sagittal and transversal development of the maxilla in cleft patients. Scand J Plast Reconstr Surg Hand Surg. 1987; 21(1):31-4. DOI: 10.3109/02844318709083576. View

BARDACH J, Kelly K . The influence of lip repair with and without soft-tissue undermining on facial growth in beagles. Plast Reconstr Surg. 1988; 82(5):747-59. DOI: 10.1097/00006534-198811000-00003. View

10.

Matarasso S, Matarasso A . Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids. Plast Reconstr Surg. 2001; 108(1):208-14; discussion 215-7. DOI: 10.1097/00006534-200107000-00033. View

11.

Wang L, Tai N, Fan Z . [Effect of botulinum toxin type A injection on hypertrophic scar in rabbit ear model]. Zhonghua Zheng Xing Wai Ke Za Zhi. 2009; 25(4):284-7. View

12.

Mahajan S, Brubaker L . Botulinum toxin: from life-threatening disease to novel medical therapy. Am J Obstet Gynecol. 2007; 196(1):7-15. DOI: 10.1016/j.ajog.2006.03.108. View

13.

Gassner H, Sherris D, Friedman O . Botulinum toxin-induced immobilization of lower facial wounds. Arch Facial Plast Surg. 2009; 11(2):140-2. DOI: 10.1001/archfacial.2009.3. View

14.

BARDACH J, Bakowska J, Mooney M, Dusdieker L . Lip pressure changes following lip repair in infants with unilateral clefts of the lip and palate. Plast Reconstr Surg. 1984; 74(4):476-81. DOI: 10.1097/00006534-198410000-00003. View

15.

Kane M . The functional anatomy of the lower face as it applies to rejuvenation via chemodenervation. Facial Plast Surg. 2005; 21(1):55-64. DOI: 10.1055/s-2005-871764. View

16.

MARTEL H, Walker D, Reed R, Bert J . Dermal fibroblast morphology is affected by stretching and not by C48/80. Connect Tissue Res. 2002; 42(4):235-44. DOI: 10.3109/03008200109016838. View

17.

Lee B, Jeong J, Wang S, Lee J, Goh E, Kim H . Effect of botulinum toxin type a on a rat surgical wound model. Clin Exp Otorhinolaryngol. 2009; 2(1):20-7. PMC: 2671832. DOI: 10.3342/ceo.2009.2.1.20. View

18.

Xiao Z, Zhang F, Lin W, Zhang M, Liu Y . Effect of botulinum toxin type A on transforming growth factor beta1 in fibroblasts derived from hypertrophic scar: a preliminary report. Aesthetic Plast Surg. 2009; 34(4):424-7. DOI: 10.1007/s00266-009-9423-z. View

19.

Aoki K . Pharmacology and immunology of botulinum toxin type A. Clin Dermatol. 2004; 21(6):476-80. DOI: 10.1016/j.clindermatol.2003.11.006. View

20.

Haubner F, Ohmann E, Muller-Vogt U, Kummer P, Strutz J, Gassner H . Effects of botulinum toxin a on cytokine synthesis in a cell culture model of cutaneous scarring. Arch Facial Plast Surg. 2011; 14(2):122-6. DOI: 10.1001/archfacial.2011.734. View